Marco Vitolo: The Odyssey of Stroke Prevention in ESRD and AF
Marco Vitolo, Attending Cardiologist, Tenure-Track Assistant Professor – University of Modena and Reggio Emilia, shared a post on LinkedIn about a recent article he and his colleagues co-authored,published in EJIM, adding:
“With The Odyssey in cinemas these days, it is a good time to revisit our clinical insight published a few months ago in EJIM
The Odyssey of stroke prevention in ESRD individuals with AF
A long and still unfinished journey towards the best strategy for stroke prevention in patients with atrial fibrillation and end-stage renal disease.
Still looking for our Ithaca
- Vitamin K antagonists: the traditional strategy, but with major limitations and no solid randomized evidence of net clinical benefit.
- DOACs: a major evolution in anticoagulation, but with ESRD and dialysis patients largely excluded from pivotal trials.
- Randomized trials in dialysis: RENAL-AF, AXADIA-AFNET and Valkyrie, which have not yet provided a definitive answer.
- Left atrial appendage occlusion — a promising non-pharmacological route, but still awaiting robust randomized evidence in ESRD.
- Factor XI inhibitors and new strategies — potentially pointing towards a safer balance between thrombosis and bleeding.”
Title: Stroke prevention in atrial fibrillation patients with end-stage renal disease: how far from Ithaca after a long Odyssey?
Authors: Davide Antonio Meia, Francesco Trittoa, Jacopo Francesco Imbertia, Marco Vitoloa, Giuseppe Boriani
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 12, 2026, 05:35Burjor Langdana: Why Does Blast Traumatised Facial Tissue Keep Swelling and often Heal Badly
-
Aug 12, 2026, 05:22Giuseppe Leone: Potential Causal Relationship between H. pylori and ITP
-
Aug 12, 2026, 03:54Edina Cenko: Looking Beyond the Epicardial Coronary Arteries
-
Aug 12, 2026, 03:10Ageing with Haemophilia – A Changing Clinical Landscape – EAHAD
-
Aug 12, 2026, 02:05Kellie Machlus: Postdoc Opening in Translational Hematology at BCH/HMS
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials